XML 108 R38.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Business Segments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2014
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment |
| Year ended December 31, 2014
| Apex |  | Oxford |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 1,190,052 |  |  | $ | 493,320 |  |  | $ | 41,369 |  |  | $ | — |  |  | $ | 1,724,741 |
Gross Profit | 335,322 |  |  | 208,607 |  |  | 13,506 |  |  | — |  |  | 557,435 |
Operating income | $ | 121,334 |  |  | $ | 66,315 |  |  | $ | 3,878 |  |  | $ | (53,745 | ) |  | 137,782 |
Amortization | 16,356 |  |  | 5,491 |  |  | 274 |  |  | 9 |  |  | 22,130 |
| Year ended December 31, 2013
| Apex |  | Oxford |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 1,059,993 |  |  | $ | 423,670 |  |  | $ | 39,438 |  |  | $ | — |  |  | $ | 1,523,101 |
Gross Profit | 294,611 |  |  | 147,348 |  |  | 12,916 |  |  | — |  |  | 454,875 |
Operating income | 98,588 |  |  | 60,544 |  |  | 5,574 |  |  | (48,119 | ) |  | 116,587 |
Amortization | 19,524 |  |  | 965 |  |  | 364 |  |  | 90 |  |  | 20,943 |
| Year ended December 31, 2012
| Apex |  |  | Oxford |  |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 617,844 |  |  | $ | 375,196 |  |  | $ | 38,895 |  |  | $ | — |  |  | $ | 1,031,935 |
Gross Profit | 174,968 |  |  | 132,034 |  |  | 14,252 |  |  | — |  |  | 321,254 |
Operating income | 57,191 |  |  | 57,703 |  |  | 4,481 |  |  | (46,362 | ) |  | 73,013 |
Amortization | 15,665 |  |  | 437 |  |  | 654 |  |  | 291 |  |  | 17,047 |
Disclosure on Geographic Areas, Description of Revenue from External Customers | The Company operates internationally, with operations in the United States, Europe, Canada, Australia, and New Zealand. The following table represents revenues by geographic location (in thousands):
|  | Year Ended December 31,
|  | 2014 |  | 2013 |  | 2012
Revenues: |  |  |  |  |  |
Domestic |  | $ | 1,643,598 |  |  | $ | 1,446,805 |  |  | $ | 958,342 |
Foreign |  | 81,143 |  |  | 76,296 |  |  | 73,593 |
|  | $ | 1,724,741 |  |  | $ | 1,523,101 |  |  | $ | 1,031,935 |
Schedule of Revenue by Geographical Areas | Business Segments The Company has three reportable segments: Apex, Oxford, and Life Sciences Europe. During the quarter ended March 31, 2014, the Company realigned its former Life Sciences Segment resulting in Lab Support U.S. now being included in the Apex Segment; Valesta U.S. now being included in the Oxford Segment; and the Life Sciences Europe Segment includes Lab Support Europe and Valesta Europe. On February 1, 2015 the Company sold the Physician Segment. During 2014 the Company discontinued the operations of its European retained search unit, formerly included in the Life Sciences Europe Segment. During 2013, the Company sold its Nurse Travel and Allied Healthcare division (see "Note 5. Discontinued Operations" for further information). The realignment and divestitures resulted in changes to the internal reporting package reviewed by the Chief Operating Decision Maker ("CODM"), and the Healthcare Segment no longer exists. Health Information Management, formerly included in the Healthcare Segment, is included in the Oxford Segment and unallocated corporate expenses are separately disclosed in order to align with the revised internal reporting package reviewed by the CODM. All prior periods have been retrospectively restated to conform to the current presentation. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions to Fortune 1000 and mid-market clients across the United States, and offers consulting services for other select project-based needs. Apex Segment provides staffing and services support for companies from all major industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications. The Oxford Segment provides high-end contract and direct hire placement services of information technology and engineering professionals with expertise in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical and environmental industries. These contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants and other skilled scientific professionals. The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit, and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes. The Company's management does not evaluate, manage or measure performance of segments using asset information, and such information is not readily available. Accordingly, assets by reportable segment are not disclosed. The following tables present revenues, gross profit, operating income and amortization by reportable segment (in thousands):
| Year ended December 31, 2014
| Apex |  | Oxford |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 1,190,052 |  |  | $ | 493,320 |  |  | $ | 41,369 |  |  | $ | — |  |  | $ | 1,724,741 |
Gross Profit | 335,322 |  |  | 208,607 |  |  | 13,506 |  |  | — |  |  | 557,435 |
Operating income | $ | 121,334 |  |  | $ | 66,315 |  |  | $ | 3,878 |  |  | $ | (53,745 | ) |  | 137,782 |
Amortization | 16,356 |  |  | 5,491 |  |  | 274 |  |  | 9 |  |  | 22,130 |
| Year ended December 31, 2013
| Apex |  | Oxford |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 1,059,993 |  |  | $ | 423,670 |  |  | $ | 39,438 |  |  | $ | — |  |  | $ | 1,523,101 |
Gross Profit | 294,611 |  |  | 147,348 |  |  | 12,916 |  |  | — |  |  | 454,875 |
Operating income | 98,588 |  |  | 60,544 |  |  | 5,574 |  |  | (48,119 | ) |  | 116,587 |
Amortization | 19,524 |  |  | 965 |  |  | 364 |  |  | 90 |  |  | 20,943 |
| Year ended December 31, 2012
| Apex |  |  | Oxford |  |  | Life Sciences Europe |  | Corporate |  | Total
Revenues | $ | 617,844 |  |  | $ | 375,196 |  |  | $ | 38,895 |  |  | $ | — |  |  | $ | 1,031,935 |
Gross Profit | 174,968 |  |  | 132,034 |  |  | 14,252 |  |  | — |  |  | 321,254 |
Operating income | 57,191 |  |  | 57,703 |  |  | 4,481 |  |  | (46,362 | ) |  | 73,013 |
Amortization | 15,665 |  |  | 437 |  |  | 654 |  |  | 291 |  |  | 17,047 |
The Company operates internationally, with operations in the United States, Europe, Canada, Australia, and New Zealand. The following table represents revenues by geographic location (in thousands):
|  | Year Ended December 31,
|  | 2014 |  | 2013 |  | 2012
Revenues: |  |  |  |  |  |
Domestic |  | $ | 1,643,598 |  |  | $ | 1,446,805 |  |  | $ | 958,342 |
Foreign |  | 81,143 |  |  | 76,296 |  |  | 73,593 |
|  | $ | 1,724,741 |  |  | $ | 1,523,101 |  |  | $ | 1,031,935 |
The following table represents long-lived assets by geographic location (in thousands):
|  | December 31,
|  | 2014 |  | 2013 |  | 2012
Long-lived Assets: |  |  |  |  |  |
Domestic |  | $ | 49,837 |  |  | $ | 42,341 |  |  | $ | 38,099 |
Foreign |  | 2,091 |  |  | 2,394 |  |  | 2,006 |
|  | $ | 51,928 |  |  | $ | 44,735 |  |  | $ | 40,105 |
Long Lived Assets By Geographic Location Domestic And Foreign | The following table represents long-lived assets by geographic location (in thousands):
|  | December 31,
|  | 2014 |  | 2013 |  | 2012
Long-lived Assets: |  |  |  |  |  |
Domestic |  | $ | 49,837 |  |  | $ | 42,341 |  |  | $ | 38,099 |
Foreign |  | 2,091 |  |  | 2,394 |  |  | 2,006 |
|  | $ | 51,928 |  |  | $ | 44,735 |  |  | $ | 40,105 |

X
- Definition Schedule Of Entity Wide Disclosure On Geographic Areas Long Lived Assets Domestic And Foreign [Table Text Block] + References No definition available. + Details
Name: | asgn_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsDomesticAndForeignTableTextBlock
Namespace Prefix: | asgn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration